Match tier
Listed
Presence
Current · Arkansas
Last published
2025
Sources
OpenAlex · ORCID
Refreshed
2026-08-08
Biography and Research Information
OverviewAI-generated summary
Cecile Bustamante-Gomez's research focuses on bone biology and remodeling, particularly in the context of animal models. Her work investigates the role of specific molecular pathways, such as RANKL signaling, in bone loss and healing. She has studied the effects of therapeutic agents like denosumab and romosozumab on bone turnover and has explored the potential of sclerostin inhibition for restoring bone health in models of multiple myeloma. Additionally, her research has involved characterizing different types of mesenchymal cells associated with bone, contributing to a deeper understanding of skeletal development and repair mechanisms. Bustamante-Gomez has published seven papers and has a citation count of 41, with an h-index of 2. She collaborates with several researchers at the University of Arkansas for Medical Sciences, including Charles A. O’Brien, Visanu Wanchai, Jinhu Xiong, and Melda Onal.
Metrics
- h-index: 3
- Publications: 7
- Citations: 58
Selected Publications
-
Healing of lytic lesions and restoration of bone health in multiple myeloma through sclerostin inhibition (2025)
-
Potent suppression of bone remodeling by denosumab does not blunt the anabolic response to romosozumab in mice (2025)
-
RANKL-mediated osteoclast formation is required for bone loss in a murine model of Staphylococcus aureus osteomyelitis (2024)
-
Refining the identity of mesenchymal cell types associated with murine periosteal and endosteal bone (2024)
-
A framework for defining mesenchymal cell types associated with murine periosteal and endosteal bone (2023)
Collaboration Network
Top Collaborators
Charles A. O’Brien
University of Arkansas for Medical Sciences
4 shared publications
In database
- Refining the identity of mesenchymal cell types associated with murine periosteal and endosteal bone
- RANKL-mediated osteoclast formation is required for bone loss in a murine model of Staphylococcus aureus osteomyelitis
- Potent suppression of bone remodeling by denosumab does not blunt the anabolic response to romosozumab in mice
- A framework for defining mesenchymal cell types associated with murine periosteal and endosteal bone
Intawat Nookaew
University of Arkansas for Medical Sciences
3 shared publications
In database
- Refining the identity of mesenchymal cell types associated with murine periosteal and endosteal bone
- A framework for defining mesenchymal cell types associated with murine periosteal and endosteal bone
- Healing of lytic lesions and restoration of bone health in multiple myeloma through sclerostin inhibition
Qiang Fu
University of Arkansas for Medical Sciences
3 shared publications
In database
- Refining the identity of mesenchymal cell types associated with murine periosteal and endosteal bone
- Potent suppression of bone remodeling by denosumab does not blunt the anabolic response to romosozumab in mice
- A framework for defining mesenchymal cell types associated with murine periosteal and endosteal bone
Jinhu Xiong
University of Arkansas for Medical Sciences
2 shared publications
In database
- Refining the identity of mesenchymal cell types associated with murine periosteal and endosteal bone
- A framework for defining mesenchymal cell types associated with murine periosteal and endosteal bone
Melda Onal
University of Arkansas for Medical Sciences
2 shared publications
In database
- Refining the identity of mesenchymal cell types associated with murine periosteal and endosteal bone
- A framework for defining mesenchymal cell types associated with murine periosteal and endosteal bone
Visanu Wanchai
University of Arkansas for Medical Sciences
2 shared publications
In database
- Refining the identity of mesenchymal cell types associated with murine periosteal and endosteal bone
- A framework for defining mesenchymal cell types associated with murine periosteal and endosteal bone
Ha‐Neui Kim
University of Arkansas for Medical Sciences
2 shared publications
In database
- Refining the identity of mesenchymal cell types associated with murine periosteal and endosteal bone
- A framework for defining mesenchymal cell types associated with murine periosteal and endosteal bone
Maria Almeida
University of Arkansas for Medical Sciences
2 shared publications
In database
- Refining the identity of mesenchymal cell types associated with murine periosteal and endosteal bone
- A framework for defining mesenchymal cell types associated with murine periosteal and endosteal bone
Humberto Reyes-Pardo
University of Arkansas for Medical Sciences
2 shared publications
In database
- RANKL-mediated osteoclast formation is required for bone loss in a murine model of Staphylococcus aureus osteomyelitis
- Potent suppression of bone remodeling by denosumab does not blunt the anabolic response to romosozumab in mice
Mara J. Campbell
University of Arkansas for Medical Sciences
1 shared publication
In database
- RANKL-mediated osteoclast formation is required for bone loss in a murine model of Staphylococcus aureus osteomyelitis
Qiang Fu
University of Arkansas for Medical Sciences (US)
1 shared publication
- RANKL-mediated osteoclast formation is required for bone loss in a murine model of Staphylococcus aureus osteomyelitis
Karen E. Beenken
University of Arkansas for Medical Sciences
1 shared publication
In database
- RANKL-mediated osteoclast formation is required for bone loss in a murine model of Staphylococcus aureus osteomyelitis
Mark S. Smeltzer
University of Arkansas for Medical Sciences
1 shared publication
In database
- RANKL-mediated osteoclast formation is required for bone loss in a murine model of Staphylococcus aureus osteomyelitis
Joseph J. Goellner
University of Arkansas for Medical Sciences
1 shared publication
In database
- Potent suppression of bone remodeling by denosumab does not blunt the anabolic response to romosozumab in mice
Jeff D. Thostenson
University of Arkansas for Medical Sciences
1 shared publication
In database
- Potent suppression of bone remodeling by denosumab does not blunt the anabolic response to romosozumab in mice
Similar Researchers
Based on overlapping research topics
Elisabeth Ferreira
University of Arkansas for Medical Sciences
Bone Metabolism and Diseases
Mesenchymal stem cell research
Pharmacological Effects and Toxicity Studies
Gareeballah Osman Adam
University of Arkansas for Medical Sciences
Bone Metabolism and Diseases
Pharmacological Effects and Toxicity Studies
Plant and animal studies
Rebekah M. Samsonraj
University of Arkansas at Fayetteville
Mesenchymal stem cell research
Pharmacological Effects and Toxicity Studies
Bone health and treatments
Silvia Marino
University of Arkansas for Medical Sciences
Bone Metabolism and Diseases
Pharmacological Effects and Toxicity Studies
Multiple Myeloma Research and Treatments
Michelle M. Vanlandingham
National Center for Toxicological Research
Pharmacological Effects and Toxicity Studies
Bone health and treatments
Plant and animal studies
Katherine D. Comer
University of Arkansas at Fayetteville
Mesenchymal stem cell research
Pharmacological Effects and Toxicity Studies
Immune Response and Inflammation